Literature DB >> 18156621

IL-27 inhibits the development of regulatory T cells via STAT3.

Magdalena Huber1, Vera Steinwald, Anna Guralnik, Anne Brüstle, Peter Kleemann, Christine Rosenplänter, Thomas Decker, Michael Lohoff.   

Abstract

Regulatory CD4+ T cells are important for the homeostasis of the immune system and their absence correlates with autoimmune disorders. Here, we investigate the capacity of IL-27, a cytokine with pro- and anti-inflammatory properties, to regulate the generation of transforming growth factor beta (TGFbeta)-inducible forkhead box P3 (Foxp3)-positive regulatory T (Treg) cells. Our results demonstrate that IL-27 inhibits the acquisition of the Treg phenotype at the level of Foxp3, CD25 and CTLA-4 (CD152) expression as well as the suppressive function. In contrast to TGFbeta-induced Treg cells, the cells generated after differentiation in the presence of TGFbeta and IL-27 maintained the ability for IL-2 and tumour necrosis factor alpha (TNFalpha) production. The inhibitory effect of IL-27 on Treg generation was at least partially signal transducer and activator of transcription 3 (STAT3) dependent as examined by targeted STAT3 protein inhibition using small interfering RNA (siRNA), while STAT1-dependent signals seemed to oppose the STAT3 signals. In turn, TGFbeta blocked IL-27-induced T(h)1 differentiation. Thus, IL-27 and TGFbeta mutually control their effects on CD4+ T-cell differentiation, whereby IL-27 favours inflammatory conditions through a STAT3-dependent inhibition of Treg generation.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18156621     DOI: 10.1093/intimm/dxm139

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  84 in total

1.  The composition and signaling of the IL-35 receptor are unconventional.

Authors:  Lauren W Collison; Greg M Delgoffe; Clifford S Guy; Kate M Vignali; Vandana Chaturvedi; DeLisa Fairweather; Abhay R Satoskar; K Christopher Garcia; Christopher A Hunter; Charles G Drake; Peter J Murray; Dario A A Vignali
Journal:  Nat Immunol       Date:  2012-02-05       Impact factor: 25.606

2.  Positive and negative transcriptional regulation of the Foxp3 gene is mediated by access and binding of the Smad3 protein to enhancer I.

Authors:  Lili Xu; Atsushi Kitani; Christina Stuelten; George McGrady; Ivan Fuss; Warren Strober
Journal:  Immunity       Date:  2010-09-24       Impact factor: 31.745

3.  PRMT1 Plays a Critical Role in Th17 Differentiation by Regulating Reciprocal Recruitment of STAT3 and STAT5.

Authors:  Subha Sen; Zhiheng He; Shubhamoy Ghosh; Kenneth J Dery; Lu Yang; Jing Zhang; Zuoming Sun
Journal:  J Immunol       Date:  2018-05-23       Impact factor: 5.422

Review 4.  Epigenetic mechanisms of regulation of Foxp3 expression.

Authors:  Girdhari Lal; Jonathan S Bromberg
Journal:  Blood       Date:  2009-07-29       Impact factor: 22.113

5.  Activation of 4-1BB on Liver Myeloid Cells Triggers Hepatitis via an Interleukin-27-Dependent Pathway.

Authors:  Todd Bartkowiak; Ashvin R Jaiswal; Casey R Ager; Renee Chin; Chao-Hsien Chen; Pratha Budhani; Midan Ai; Matthew J Reilley; Manu M Sebastian; David S Hong; Michael A Curran
Journal:  Clin Cancer Res       Date:  2018-01-04       Impact factor: 12.531

6.  Absence of specific alternatively spliced exon of CD44 in macrophages prevents colitis.

Authors:  B M Wittig; R Sabat; P Holzlöhner; E Witte-Händel; K Heilmann; K Witte; J Triebus; A Tzankov; J D Laman; B Bokemeyer; L Terracciano; C Schwärzler; H Kohler; R Volkmer; C Loddenkemper; K Wolk; U Hoffmann; U Günthert
Journal:  Mucosal Immunol       Date:  2017-11-29       Impact factor: 7.313

7.  Systemic delivery of IL-27 by an adeno-associated viral vector inhibits T cell-mediated colitis and induces multiple inhibitory pathways in T cells.

Authors:  Xiaotong Zhu; Zhihao Liu; Jin-Qing Liu; Jianmin Zhu; Jianchao Zhang; Jonathan P Davis; Jianhong Chu; Jianhua Yu; Jie Zhou; Ming-Song Li; Xue-Feng Bai
Journal:  J Leukoc Biol       Date:  2016-04-22       Impact factor: 4.962

8.  Immunologic and therapeutic synergy of IL-27 and IL-2: enhancement of T cell sensitization, tumor-specific CTL reactivity and complete regression of disseminated neuroblastoma metastases in the liver and bone marrow.

Authors:  Rosalba Salcedo; Julie A Hixon; Jimmy K Stauffer; Rashmi Jalah; Alan D Brooks; Tahira Khan; Ren-Ming Dai; Loretta Scheetz; Erin Lincoln; Timothy C Back; Douglas Powell; Arthur A Hurwitz; Thomas J Sayers; Robert Kastelein; George N Pavlakis; Barbara K Felber; Giorgio Trinchieri; Jon M Wigginton
Journal:  J Immunol       Date:  2009-04-01       Impact factor: 5.422

Review 9.  Interleukin-27: balancing protective and pathological immunity.

Authors:  Christopher A Hunter; Rob Kastelein
Journal:  Immunity       Date:  2012-12-14       Impact factor: 31.745

10.  Regulation of the IL-23 and IL-12 balance by Stat3 signaling in the tumor microenvironment.

Authors:  Marcin Kortylewski; Hong Xin; Maciej Kujawski; Heehyoung Lee; Yong Liu; Timothy Harris; Charles Drake; Drew Pardoll; Hua Yu
Journal:  Cancer Cell       Date:  2009-02-03       Impact factor: 31.743

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.